Carregant...
Genome-Wide Association Study of Short-Acting β(2)-Agonists. A Novel Genome-Wide Significant Locus on Chromosome 2 near ASB3
Rationale: β(2)-Agonists are the most common form of treatment of asthma, but there is significant variability in response to these medications. A significant proportion of this responsiveness may be heritable. Objectives: To investigate whether a genome-wide association study (GWAS) could identify...
Guardat en:
| Publicat a: | Am J Respir Crit Care Med |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Thoracic Society
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4384768/ https://ncbi.nlm.nih.gov/pubmed/25562107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201408-1426OC |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|